A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, revealing a much-needed new therapy route for this important class of drug targets.
Chinese Medical Journals Publishing House Co., Ltd. Brain cancer is one of the most aggressive and life-threatening diseases, with glioblastoma (GBM) being the most common and deadliest type. Patients ...
SEATTLE--(BUSINESS WIRE)--Kayothera, Inc. (“Kayothera”), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the retinoid nuclear receptor pathway, today ...
(MEMPHIS, Tenn. – November 6, 2025) A study from St. Jude Children’s Research Hospital uncovered an alternative binding pocket within nuclear receptors, revealing a much-needed new therapy route for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results